BRAF and melanoma: Furthermore, the mutation status of the BRAF gene and the use of BRAF inhibitors both influence the oxidative metabolism and oxidative phosphorylation levels of melanoma cells, potentially determining their sensitivity to ferroptosis inducers (185).